Examination of a fresh frozen plasma dosage and administration timing, and the protamine dose before and after cardio-pulmonary bypass.

Examination of a fresh frozen plasma dosage and administration timing, and the protamine dose before and after cardio-pulmonary bypass. - Change of the blood coagulation system before and after cardio-pulmonary bypass.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019715

Enrollment

Registered

2015-11-09

Start date

2015-11-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the case of cardiovascular surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients performed cardio-vascular surgery

Exclusion criteria

Exclusion criteria: The person who do not hop to be a target person. Person having blood disorder. The person whose a record is insufficient.

Design outcomes

Primary

Measure	Time frame
Examination of protamine initial dosage at the time of the cardio-pulmonary bypass and the additional dose	—

Countries

Japan

Contacts

Public ContactKazuhiro Shirozu

Kyushu university hospital operating room

shiron@kuaccm.med.kyushu-u.ac.jp092-642-5714

Outcome results